KIT, KIT proto-oncogene, receptor tyrosine kinase, 3815
N. diseases: 715; N. variants: 92
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.040 | 4 | 54656321 | upstream gene variant | G/T | snv | 0.54 |
|
0.020 | 0.500 | 2 | 2012 | 2012 | ||||||||
|
0.882 | 0.080 | 4 | 54675713 | intron variant | T/C | snv | 0.60 |
|
0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.732 | 0.240 | 4 | 54727298 | missense variant | A/C;G;T | snv | 7.7E-02; 8.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 4 | 54727265 | missense variant | G/A | snv | 5.5E-04 | 1.2E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
1.000 | 0.080 | 4 | 54733118 | missense variant | C/T | snv | 1.2E-05 | 7.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | |||||||||
|
1.000 | 0.080 | 4 | 54731395 | missense variant | G/A | snv | 8.0E-06 | 7.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | |||||||||
|
0.925 | 0.120 | 4 | 54731930 | missense variant | G/T | snv | 4.0E-06 | 3.5E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.695 | 0.280 | 4 | 54733166 | missense variant | G/C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.677 | 0.320 | 4 | 54733154 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Neoplasms; Immune System Diseases | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||||||
|
0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Neoplasms; Immune System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 4 | 54727438 | stop gained | G/A;C | snv | 4.0E-06 |
|
0.700 | 0 | ||||||||||||
|
0.695 | 0.280 | 4 | 54733166 | missense variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 1996 | 1998 | ||||||||
|
0.677 | 0.320 | 4 | 54733154 | missense variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 1996 | 1998 | ||||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.605 | 0.400 | 4 | 54733167 | missense variant | A/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.614 | 0.400 | 4 | 54733155 | missense variant | A/T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 |